- Home
- ZLAB vs AVPT Comparison
ZLAB vs AVPT Comparison
Compare ZLAB & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | AVPT |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | China | United States |
| Employees | N/A | 3443 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | AVPT |
|---|---|---|
| Price | $25.65 | $13.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $49.60 | $16.64 |
| AVG Volume (30 Days) | 818.3K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $25.00 |
| Revenue Next Year | $26.03 | $19.63 |
| P/E Ratio | ★ N/A | $1,348.94 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $8.84 |
| 52 Week High | $34.72 | $15.89 |
Technical Indicators
Market Signals| Indicator | ZLAB | AVPT |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 49.96 |
| Support Level | $24.81 | $12.82 |
| Resistance Level | $27.22 | $13.71 |
| Average True Range (ATR) | 0.90 | 0.40 |
| MACD | -0.23 | -0.03 |
| Stochastic Oscillator | 51.30 | 44.79 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About AVPT AvePoint Inc.
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.